Kilroy Realty (KRC) Q4 2024 earnings summary

Executive summary

• Achieved highest quarterly and annual leasing volumes since 2019, with over 700,000 sq. ft. leased in Q4 2024 and 1,778,000 sq. ft. for the year, reflecting strong recovery in West Coast markets.

• Portfolio focused on Class A office and life science properties in major West Coast markets, totaling 17.1M RSF and 82.8% stabilized occupancy at year-end 2024.

• Tenant base includes high-quality, investment-grade companies, with technology and life sciences representing 71% of ABR.

• Completed major development milestones, including Kilroy Oyster Point Phase II, now fully operational and attracting significant tenant interest.

• Implemented cost-saving initiatives, including the sale of the corporate airplane and a reduction in G&A and leasing costs.

Financial highlights

• Q4 2024 FFO was $1.20 per diluted share, impacted by one-time items totaling $0.11 per share, including a $6M gain on the sale of the corporate plane.

• Q4 2024 revenues were $286.4M (up from $269.0M in Q4 2023); net income available to common stockholders was $59.5M ($0.50/share), up from $47.3M ($0.40/share) year-over-year.

• Full year 2024 revenues reached $1,135.6M; net income was $211.0M ($1.77/share).

• G&A and leasing costs declined to just under $81M in 2024 from $100M in 2023.

• Declared and paid a quarterly dividend of $0.54/share ($2.16 annualized), with a 44% FFO payout ratio and 6.1% dividend yield.

Outlook and guidance

• 2025 FFO guidance is $3.85–$4.05 per diluted share, midpoint $3.95; net income per diluted share expected at $1.01–$1.22.

• 2025 average occupancy expected between 80–82%, about 300 basis points lower than 2024.

• Cash Same Property NOI projected to decline by -1.5% to -3% in 2025, with lower growth in the second half due to occupancy and non-recurring income.

• Guidance excludes potential impacts from future acquisitions, dispositions, or capital markets activity.

• Overhead guidance for 2025 is $83–$85M, reflecting a normalized run rate.